KROMITE'S Pharmaceutical Consulting services help you make tough investment decisions that involve High Value, High Risk and High Strategic Importance. 

Our engagements typically fall into four categories across drugs in development and life-cycle management:

Asset Strategy

KROMITE's Pharma team at the BIO International Conference.

Licensing and Acquisition Variations

We utilize proven Decision Science methodologies that allow us to deliver more than just valuations and models, identifying key value drivers and turning these hidden insights into actionable recommendations.

KROMITE'S senior pharma leaders all have 20 years of executive-level industry experience, so there will be no wasted time getting up to speed and delivering results. Our broad staff experience includes roles in Portfolio Management, Forecasting, Strategic Marketing, and Business Development covering a multitude of therapeutic areas including Oncology, Immunology, Orphan Diseases, and Specialty-care areas.

We’ve been in business for more than 13 years supporting both branded and generic sectors with a staff of 12 full-time and 8 supporting bench players. We are small enough to be fast and flexible, yet large enough to handle any size engagement.

Contact us today and discuss your challenges:

Email:, or call us at (908) 705-5557.

White Papers and Case Studies


Maximizing the Value of a New Molecule

Indication Sequencing for a New Molecular Entity with Multiple Potential Indications

Valuation of Pharmaceutical Drugs

Immunotherapy Oncology Drug Valuation and Development Strategy

Tough Decisions in the Pharmaceutical Industry

Assessing Risk and Value of a Project with Multiple Options,

Accounting for Uncertain Target Product Profiles (TPPs) of the Competition,

Assessing an In-Licensing Opportunity

Please reload